These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 10577976)

  • 1. Etanercept: therapeutic use in patients with rheumatoid arthritis.
    Garrison L; McDonnell ND
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I65-9. PubMed ID: 10577976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR; Keating GM
    Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept (Enbrel): update on therapeutic use.
    Spencer-Green G
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i46-9. PubMed ID: 11053088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.
    Fleischmann R; Iqbal I; Nandeshwar P; Quiceno A
    Drug Saf; 2002; 25(3):173-97. PubMed ID: 11945114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etanercept Immunex.
    Yung RL
    Curr Opin Investig Drugs; 2001 Feb; 2(2):216-21. PubMed ID: 11816834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etanercept: long-term clinical experience in rheumatoid arthritis and other arthritis.
    Cobo-Ibáñez T; Martín-Mola E
    Expert Opin Pharmacother; 2007 Jun; 8(9):1373-97. PubMed ID: 17563271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on etanercept in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR; Keating GM
    BioDrugs; 2003; 17(2):139-45. PubMed ID: 12641492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
    Weinblatt ME; Kremer JM; Bankhurst AD; Bulpitt KJ; Fleischmann RM; Fox RI; Jackson CG; Lange M; Burge DJ
    N Engl J Med; 1999 Jan; 340(4):253-9. PubMed ID: 9920948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.
    Schiff MH; Yu EB; Weinblatt ME; Moreland LW; Genovese MC; White B; Singh A; Chon Y; Woolley JM
    Drugs Aging; 2006; 23(2):167-78. PubMed ID: 16536638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept: a review of its use in rheumatoid arthritis.
    Jarvis B; Faulds D
    Drugs; 1999 Jun; 57(6):945-66. PubMed ID: 10400407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept in rheumatoid arthritis.
    Alldred A
    Expert Opin Pharmacother; 2001 Jul; 2(7):1137-48. PubMed ID: 11583065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept: a review of its use in the management of rheumatoid arthritis.
    Dhillon S; Lyseng-Williamson KA; Scott LJ
    Drugs; 2007; 67(8):1211-41. PubMed ID: 17521223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ; van de Putte LB; Breedveld FC
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept in arthritis.
    Scott DL
    Int J Clin Pract; 2005 Jan; 59(1):114-8. PubMed ID: 15707475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study.
    Lan JL; Chou SJ; Chen DY; Chen YH; Hsieh TY; Young M
    J Formos Med Assoc; 2004 Aug; 103(8):618-23. PubMed ID: 15340661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with soluble TNF p75 receptor in rheumatoid arthritis.
    Franklin CM
    Semin Arthritis Rheum; 1999 Dec; 29(3):172-81. PubMed ID: 10622681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with etanercept for patients with juvenile rheumatoid arthritis in Taiwan--a preliminary report.
    Liang TC; Yang YH; Lin YT; Chiang BL
    J Microbiol Immunol Infect; 2005 Dec; 38(6):447-50. PubMed ID: 16341347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease.
    Cole P; Rabasseda X
    Drugs Today (Barc); 2004 Apr; 40(4):281-324. PubMed ID: 15190385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice.
    Kievit W; Fransen J; Oerlemans AJ; Kuper HH; van der Laar MA; de Rooij DJ; De Gendt CM; Ronday KH; Jansen TL; van Oijen PC; Brus HL; Adang EM; van Riel PL
    Ann Rheum Dis; 2007 Nov; 66(11):1473-8. PubMed ID: 17426065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.